Positive and Negative Psychological Predictors of Long-Term Recovery after Cardiac Arrest
心脏骤停后长期恢复的积极和消极心理预测因素
基本信息
- 批准号:10542763
- 负责人:
- 金额:$ 74.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-05 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAffectAmerican Heart AssociationAutonomic nervous systemAwarenessBehaviorBehavioral MechanismsBehavioral MedicineBeliefCardiacCardiac DeathCardiac healthCardiovascular DiseasesCardiovascular systemCause of DeathCharacteristicsChestClinical Practice GuidelineDangerousnessDevelopmentDiseaseDistressEcological momentary assessmentEnrollmentEventFrequenciesFutureHappinessHealthHealth CampaignHealthcareHeartHeart ArrestHospitalizationHospitalsHourHumanImpairmentImplantable DefibrillatorsImplantation procedureInpatientsIntensive Care UnitsInterventionLifeLinkLiteratureLong-Term SurvivorsMeasuresMedicalMental DepressionMethodsMonitorMyocardial InfarctionNeurologicNew YorkOutcomeParticipantPatientsPersonsPhysical activityPopulationPost-Traumatic Stress DisordersPredictive FactorPresbyterian ChurchPsyche structurePsychological FactorsPsychological TestsPublic HealthQuality of lifeRecording of previous eventsRecoveryReportingResearchResourcesRiskRisk FactorsRoleSamplingShapesStrokeSurveysSurvival RateSurvivorsSymptomsSystemTelephoneTestingVentricular ArrhythmiaWorkWristactigraphyacute carecardioprotectioncardiovascular disorder riskcohortdepressive symptomsdisabilityethnic diversityexperiencefollow up assessmenthealth related quality of lifeheart rate variabilityheart rhythmimprovedindexinginfancyinterestlong term recoverymortalitymortality risknegative affectobservational cohort studyoptimismpatient populationpatient screeningpreventprimary outcomeprospectivepsychologicpsychological distresspsychosocialracial diversityrecruitrisk predictionsudden cardiac deathsurvivorship
项目摘要
With advances in healthcare and effective public health campaigns, the survival rate after cardiac arrest (CA)
has more than doubled during the last decade. However, as highlighted by a scientific statement from the
American Heart Association in 2020, CA patients remain at markedly elevated risk for poor long-term recovery
after leaving the hospital. We have shown that the experience of CA can be a psychologically distressing event
that induces depressive and posttraumatic stress disorder (PTSD) symptoms in >30% of patients. Further,
these symptoms were associated with a tripling of risk for secondary cardiovascular disease (CVD) and
mortality risk in our prior work. Despite a growing interest in conducting psychological interventions, there is
no reliable method for preventing negative psychological factors (NPF) after acute cardiac events. Critically,
modifiable positive psychological factors (PPF) are associated with improved quality of life (QoL), greater
independence in activities of daily living (ADL), healthier behaviors, improved (higher) cardiac vagal control,
fewer adverse cardiovascular events, and lower risk of dying in CVD patients. The most promising PPF in this
regard are a sense of optimism, experiences of positive affect, and a belief that one’s life has purpose even in
the face of the depression and distress that often follow serious cardiac events. It is unknown whether CA
survivors may benefit from PPF in the same way as other CVD patients seem to do. Although the rates of
elevated NPF are even higher in patients after CA than in patients after heart attack and stroke, many CA
survivors actually report a positive attitude and a belief that they have a fortuitous opportunity for “a second
chance at life.” The first aim of the study is to test whether PPF and NPF are associated with the measures of
recovery that are most important to patients’ everyday lives—QoL and ADL—in the year after the CA in a
racially and ethnically diverse sample of CA survivors. The second aim is to test whether PPF and NPF are
associated with a potential behavioral mechanism underlying recovery: changes in physical activity in the first
6 months after the CA. The third aim is to determine the demographic and medical factors that predict who
develops PPF and NPF after CA. We will enroll a cohort of 228 CA patients from the intensive care units (ICU)
of NewYork-Presbyterian Hospital. We will assess patients’ PPF and NPF at hospital discharge (median 21 days
post-CA). We will conduct follow-up assessments by phone at 3, 6, and 12 months after the CA. In the week
immediately following hospital discharge and again 6 months later, we will monitor physical activity via wrist-
worn actigraphy, daily positive and negative affect using mobile ecological momentary assessment, and cardiac
vagal control via a chest patch. CA accounts for more than half of all cardiac deaths, and is the third leading
cause of death and disability in the US. Malleable PPF and NPF may be targets for improving QoL and
returning CA survivors to independent lives. This study will be the first to test the potentially cardioprotective
PPF and the potentially harmful NPF to investigate how long-term recovery after CA may be improved.
随着医疗保健的进步和有效的公共卫生运动,心脏骤停(CA)后的存活率
在过去十年中增加了一倍多。然而,正如科学声明所强调的那样
美国心脏协会 2020 年 CA 患者长期恢复不良的风险仍显着升高
出院后。我们已经证明,CA 的经历可能是一种心理上令人痛苦的事件
导致 30% 以上的患者出现抑郁和创伤后应激障碍 (PTSD) 症状。更远,
这些症状与继发性心血管疾病 (CVD) 风险增加三倍相关
我们之前的工作中存在死亡风险。尽管人们对进行心理干预越来越感兴趣,但
没有可靠的方法来预防急性心脏事件后的负面心理因素(NPF)。关键的是,
可改变的积极心理因素(PPF)与生活质量(QoL)的改善相关,
日常生活活动(ADL)的独立性、更健康的行为、改善(更高)的心脏迷走神经控制、
不良心血管事件较少,心血管疾病患者的死亡风险较低。这方面最有前途的PPF
尊重是一种乐观的感觉、积极情感的体验以及相信一个人的生活即使在
严重心脏事件后经常出现的抑郁和痛苦的表情。不知道CA是否
幸存者可能会像其他 CVD 患者一样从 PPF 中受益。尽管费率
CA 后患者的 NPF 升高甚至高于心脏病发作和中风后的患者,许多 CA
幸存者实际上报告了一种积极的态度,并相信他们有一个偶然的机会“第二次”
人生的机会。”本研究的首要目的是测试 PPF 和 NPF 是否与以下措施相关:
CA 后一年内对患者日常生活最重要的恢复(QoL 和 ADL)
CA 幸存者的种族和民族多样化样本。第二个目的是测试 PPF 和 NPF 是否
与恢复背后的潜在行为机制相关:首先身体活动的变化
CA 后 6 个月。第三个目标是确定预测谁的人口和医疗因素
CA 后出现 PPF 和 NPF。我们将招募来自重症监护病房 (ICU) 的 228 名 CA 患者
纽约长老会医院。我们将评估患者出院时的 PPF 和 NPF(中位 21 天)
CA 后)。我们将在 CA 后 3、6 和 12 个月通过电话进行后续评估。本周内
出院后立即以及 6 个月后,我们将通过手腕监测身体活动
佩戴的体动记录仪、使用移动生态瞬时评估的日常积极和消极情绪以及心脏
通过胸部贴片控制迷走神经。 CA 占所有心脏死亡的一半以上,是第三大原因
美国死亡和残疾的原因。可塑性 PPF 和 NPF 可能是改善生活质量和
让 CA 幸存者回归独立生活。这项研究将是第一个测试潜在心脏保护作用的研究
PPF 和潜在有害的 NPF 来研究如何改善 CA 后的长期恢复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Lee Birk其他文献
Jeffrey Lee Birk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Lee Birk', 18)}}的其他基金
Positive and Negative Psychological Predictors of Long-Term Recovery after Cardiac Arrest
心脏骤停后长期恢复的积极和消极心理预测因素
- 批准号:
10324578 - 财政年份:2021
- 资助金额:
$ 74.43万 - 项目类别:
Investigating fear of recurrence as a modifiable mechanism of behavior change to improve medication adherence in acute coronary syndrome patients
研究对复发的恐惧作为行为改变的可修改机制,以提高急性冠脉综合征患者的药物依从性
- 批准号:
9607756 - 财政年份:2018
- 资助金额:
$ 74.43万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 74.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 74.43万 - 项目类别:
Operating Grants














{{item.name}}会员




